Source: https://code.dccouncil.us/dc/council/code/titles/7/chapters/16B/
Timestamp: 2019-04-26 06:24:38+00:00

Document:
D.C. Law Library - Chapter 16B. Use of Marijuana for Medical Treatment.
§ 7–1671.02. Use of medical marijuana.
§ 7–1671.03. Restrictions on use of medical marijuana.
§ 7–1671.07. Health Occupations Boards review of medical marijuana authorized practitioner recommendations.
§ 7–1671.09. Medical Marijuana Advisory Committee.
§ 7–1671.12. Public and private insurance.
(1) "Adjacent" means located within the same physical structure as, and is abutting, adjoining, bordering, touching, contiguous to, or otherwise physically meeting.
(1A) “Administer” or “administration” means the direct introduction of medical marijuana, whether by inhalation, ingestion, or any other means, into the body of a person.
(1B) "Advanced practice registered nurse" means an individual licensed and in good standing to practice advanced practice registered nursing under District law.
(1C) "Authorized practitioner" means a physician, advanced practice registered nurse, physician assistant, dentist, or naturopathic physician who is licensed and in good standing to practice under District law.
(B) Has responsibility for the ongoing care and treatment of the patient.
(4) “Controlled Substances Act” means Unit A of Chapter 9 of Title 48 [ § 48-901.02 et seq.].
(5) “Cultivation center” means a facility operated by an organization or business registered with the Mayor pursuant to § 7-1671.05 from or at which medical marijuana is cultivated, possessed, manufactured, and distributed in the form of medical marijuana, and paraphernalia is possessed and distributed to dispensaries.
(5A) "Dentist" means an individual who is licensed and in good standing to practice dentistry under District law, but does not include an individual who only holds a dental teaching license.
(6) “Department” means the Department of Health.
(7) “Dispensary” means a facility operated by an organization or business registered with the Mayor pursuant to § 7-1671.05 from or at which medical marijuana is possessed and dispensed and paraphernalia is possessed and distributed to a qualifying patient or a caregiver.
(8) “Dispense” means to distribute medical marijuana to a qualifying patient or caregiver pursuant to this chapter and the rules issued pursuant to § 7-1671.13.
(9) “Distribute” means the actual, constructive, or attempted transfer from one person to another.
(10) “Manufacture” means the production, preparation, propagation, compounding, conversion, or processing of marijuana, either directly or indirectly by extraction from substances of natural origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis, and includes any packaging or repackaging of the substance or labeling or re-labeling of its container.
(11) “Marijuana” shall have the same meaning as provided in § 48-901.02(3)(A).
(12) “Medical marijuana” means marijuana cultivated, manufactured, possessed, distributed, dispensed, obtained, or administered in accordance with this chapter and the rules issued pursuant to § 7-1671.13.
(12A) "Medical marijuana product" means a product derived from or composed of medical marijuana, in part or in whole.
(13) “Minor” means any person under 18 years of age, but does not include an emancipated minor.
(13A) "Naturopathic physician" means an individual who is licensed and in good standing to practice naturopathic medicine under District law.
(B) Kits, objects, devices, or equipment used, intended for use, or designed for use in planting, propagating, manufacturing, cultivating, growing, harvesting, processing, or preparing medical marijuana.
(15) “Physician” means an individual who is licensed and in good standing to practice medicine or osteopathy under District law.
(15A) "Physician assistant" means an individual who is licensed and in good standing to practice as a physician assistant under District law.
(16) “Program” means the medical marijuana program established by § 7-1671.05.
(17) “Qualifying medical or dental condition” means any condition for which treatment with medical marijuana would be beneficial, as determined by the patient’s authorized practitioner.
(D) Any other treatment, as determined by rulemaking, whose side effects require treatment through the administration of medical marijuana in the same manner as a qualifying medical or dental condition.
(19) “Qualifying patient” means a resident of the District who has a qualifying medical or dental condition or is undergoing a qualifying medical or dental treatment, or a patient enrolled in another jurisdiction's medical marijuana program; provided, that a patient from another jurisdiction shall not be a qualifying patient if the Department determines that there is a shortage of medical marijuana or the real-time electronic records system referenced in § 7-1671.05(4)(A) is inactive.
(19A) "Real-time electronic records" means a records system that is able to track the amount of medical marijuana that District residents and patients from another jurisdiction purchase in real-time.
(20) “Residence” means a dwelling or dwelling unit in which a person lives in a particular locality with the intent to make it a fixed and permanent home.
(21) "Testing laboratory" means an entity that is not owned or operated by a director, officer, member, incorporator, agent, or employee of a cultivation center or dispensary, and is registered by the Department to test medical marijuana and medical marijuana products that are to be sold under this chapter.
This section is referenced in § 3-1202.03, § 48-904.01, and § 48-1103.
The 2015 amendment by D.C. Law 20-189 rewrote (17).
For temporary (90 days) amendment of this section, see § 2(a) of Medical Marijuana Cultivation Center Expansion Congressional Review Emergency Amendment Act of 2016 (D.C. Act 21-475, July 21, 2016, 63 DCR 10179).
For temporary (90 days) amendment of this section, see § 2(a)(1A) of Medical Marijuana Cultivation Center Expansion Emergency Amendment Act of 2016 (D.C. Act 21-396, May 19, 2016, 63 DCR 7908).
For temporary (90 days) amendment of this section, see § 2(a) of Medical Marijuana Expansion Congressional Review Emergency Amendment Act of 2015 (D.C. Act 21-3, Feb. 19, 2015, 62 DCR 2468).
For temporary (90 day) addition, see § 2 of Legalization of Marijuana for Medical Treatment Initiative Applicability Emergency Amendment Act of 2009 (D.C. Act 18-323, March 1, 2010, 57 DCR 1849).
For temporary (90 days) amendment of this section, see § 2(a) of the Medical Marijuana Expansion Emergency Amendment Act of 2014 (D.C. Act 20-396, July 29, 2014, 61 DCR 8255).
For temporary (90 days) amendment of this section, see § 2(a) of the Medical Marijuana Expansion Congressional Review Emergency Amendment Act of 2014 (D.C. Act 20-479, Nov. 12, 2014, 61 DCR 12129, 20 STAT 4403).
For temporary (90 days) amendment of this section, see § 2(a) of the Medical Marijuana Cultivation Center Expansion Emergency Amendment Act of 2015 (D.C. Act 21-104, July 20, 2015, 62 DCR 9965).
For temporary (90 days) amendment of this section, see § 2(a) of the Medical Marijuana Cultivation Center Expansion Congressional Review Emergency Amendment Act of 2015 (D.C. Act 21-156, Oct. 16, 2015, 62 DCR 13707).
For temporary (225 days) amendment of this section, see § 2(a) of Medical Marijuana Cultivation Center Expansion Temporary Amendment Act of 2016 (D.C. Law 21-146, Aug. 19, 2016, 63 DCR 9282).
Section 4(b) of D.C. Law 18-152 provided that the act shall expire after 225 days of its having taken effect.
For temporary (225 days) amendment of this section, see § 2(a) of the Medical Marijuana Expansion Temporary Amendment Act of 2014 (D.C. Law 20-163, February 26, 2015, 60 DCR 10753).
For temporary (225 days) amendment of this section, see § 2(a) of the Medical Marijuana Cultivation Center Expansion Temporary Amendment Act of 2015 (D.C. Law 21-33, Oct. 21, 2015, 62 DCR 10896).
History of D.C. Law 13-315.
Initiative 59, permitting the use of marijuana for medical treatment, was certified as a proper subject for an initiative by the District of Columbia Board of Elections and Ethics on September 17, 1998. In reaction to the certification, Congress enacted and the President signed the “Barr Amendment” that prohibited the use of appropriated funds to conduct any ballot initiative which sought to legalize or otherwise reduce penalties associated with a controlled substance. Since, the ballots for the November 3 election had already been printed before enactment of the Barr Amendment, District voters still considered the initiative.
After the vote, the Board of Elections and Ethics refused, in light of the Barr Amendment, to release and certify the results of the vote on Initiative 59. Certain District of Columbia voters then sued the Board.
In Turner v. District of Columbia Board of Elections and Ethics, 77 F.Supp.2d 25 (D.D.C. 1999), the court ruled that the Board could count and certify the election results concerning Initiative 59. After the count, the Board announced that Initiative 59 had been approved by the voters and certified the results. The initiative was eventually assigned D.C. Act 13-138.
On October 20, 1999, the District of Columbia Chief Financial Officer (“CFO”) submitted a fiscal impact statement that found that implementation of Act 13-138 would have a fiscal impact and recommended that the cost be included in the development of the fiscal year 2001 budget.
On October 25, 1999, the District of Columbia Council transmitted D.C. Act 13-138 to the District of Columbia Financial Responsibility and Management Assistance Authority (“Control Board”).
On October 26, 1999, the Control Board informed the Council that it would not accept D.C. Act 13-138 without a revised fiscal impact statement from the CFO.
On September 30, 2001, the Control Board suspended its activities.
Between 1998 and 2009 all District of Columbia appropriations acts contained language that prevented Initiative 59 from taking effect as law. Congress did not include the language in the District of Columbia Appropriations Act, 2010 (Pub. L. 111-117).
With the removal of the “Bar Amendment”, the Council transmitted Act 13-138 to Congress on December 21, 2009, for a 30-day period of review.
Establishment of Medical Marijuana Program Pursuant to the Legalization of Marijuana for Medical Treatment Initiative of 1999, see Mayor’s Order 2011-71, April 13, 2011 ( 58 DCR 3527).
(a) Notwithstanding any other District law, a qualifying patient may possess and administer medical marijuana, and possess and use paraphernalia, in accordance with this chapter and the rules issued pursuant to § 7-1671.13.
(b) Notwithstanding any other District law, a caregiver may possess and dispense medical marijuana to a qualifying patient, and possess and use paraphernalia, for the sole purpose of assisting in the administration of medical marijuana to a qualifying patient in accordance with this chapter and the rules issued pursuant to § 7-1671.13.
(2) Enrolled in another jurisdiction's medical marijuana program.
(d) A qualifying patient or caregiver shall only possess, administer, or dispense medical marijuana, or possess or use paraphernalia, obtained from a dispensary registered with the Mayor pursuant to § 7-1671.05.
(4) Consents to, or designates another adult to, serve as the caregiver for the qualifying patient and the caregiver controls the acquisition, possession, dosage, and frequency of use of medical marijuana by the qualifying patient.
Applicability of D.C. Law 21-209: § 4 of D.C. Law 21-209 provided that the change made to this section by § 2(b) of D.C. Law 21-209 is subject to the inclusion of the law’s fiscal effect in an approved budget and financial plan. Therefore that amendment has not been implemented.
(a) The maximum amount of medical marijuana that any qualifying patient or caregiver may possess at any moment is 2 ounces of dried medical marijuana; provided, that the Mayor, through rulemaking, may increase the quantity of dried medical marijuana that may be possessed up to 4 ounces; and shall promulgate through rulemaking limits on medical marijuana of a form, other than dried.
(b)(1) Medical marijuana shall not be administered by or to a qualifying patient anywhere other than the qualifying patient's residence, if permitted, the residence of an individual who has given permission to the qualifying patient to administer medical marijuana at his or her residence, if permitted, or at a medical treatment facility when receiving medical care for a qualifying medical condition, if permitted by the facility.
(2) A qualifying patient or caregiver shall not administer medical marijuana at a dispensary, cultivation center, or testing laboratory.
(3) Notwithstanding paragraph (1) of this subsection, a qualifying patient shall not use medical marijuana if exposure to the medical marijuana or the medical marijuana smoke would adversely affect the health, safety, or welfare of a minor.
(c) A qualifying patient or caregiver shall transport medical marijuana in a labeled container or sealed package in a manner and method established by rulemaking.
(2) Operate, navigate, or be in actual physical control of any motor vehicle, aircraft, or motorboat while under the influence of medical marijuana.
(e) The use of medical marijuana as authorized by this chapter and the rules issued pursuant to § 7-1671.13 does not create a defense to any crime and does not negate the mens rea element for any crime except to the extent of the voluntary-intoxication defense recognized in District of Columbia law.
(f) Notwithstanding any other law, a person or entity may provide information about the existence or operations of a dispensary, cultivation center, or testing laboratory to another person pursuant to this law.
(g) A qualified patient, caregiver, or an employee of a dispensary, cultivation center, or testing laboratory who is stopped by the police upon reasonable suspicion or probable cause that the stopped individual is in possession of marijuana may not be further detained or arrested on this basis alone if the police determine that he or she is in compliance with this chapter and the rules issued pursuant to § 7-1671.13.
(2) Makes the recommendation based upon the authorized practitioner's assessment of the qualifying patient’s medical or dental history, current medical or dental condition, and a review of other approved medications and treatments that might provide the qualifying patient with relief from a qualifying medical or dental condition or the side effects of a qualifying medical or dental treatment.
(B) A statement that the use of medical marijuana is necessary for the treatment of a qualifying medical or dental condition or the side effects of a qualifying medical or dental treatment.
(2) An authorized practitioner's recommendation shall be valid only if it is written on a form prescribed by the Mayor.
(c) Except as provided in § 7-1671.07, a physician [an authorized practitioner] shall not be subject to any penalty, including arrest, prosecution, or disciplinary proceeding, or denial of any right or privilege, for advising a qualifying patient about the use of medical marijuana or recommending the use of medical marijuana to a qualifying patient pursuant to this chapter and the rules issued pursuant to § 7-1671.13.
(d) An authorized practitioner recommending the use of medical marijuana by a qualifying patient shall not have a professional office located at a dispensary, cultivation center, or testing laboratory or receive financial compensation from a dispensary, cultivation center, or testing laboratory, or a director, officer, member, incorporator, agent, or employee of a dispensary, cultivation center, or testing laboratory.
This section is referenced in § 3-1202.03 and § 7-1671.02.
(a) Notwithstanding any other District law, a dispensary may possess medical marijuana for the purpose of dispensing the medical marijuana to a qualifying patient or caregiver and may manufacture, purchase, possess, distribute, and use paraphernalia, in accordance with this chapter and the rules issued pursuant to § 7-1671.13.
(b) Notwithstanding any other District law, a cultivation center may cultivate and possess medical marijuana for the purpose of distribution to a dispensary and may manufacture, purchase, possess, and use paraphernalia in accordance with this chapter and the rules issued pursuant to § 7-1671.13.
(b-1) Notwithstanding any other District law, a testing laboratory may possess medical marijuana for the purpose of testing its contents, in accordance with this chapter and the rules issued pursuant to § 7-1671.13.
(c) A dispensary may dispense medical marijuana and distribute paraphernalia to a qualifying patient or the qualifying patient’s caregiver, and a qualifying patient or the qualifying patient’s caregiver may obtain medical marijuana and paraphernalia from a dispensary, only if the qualifying patient is registered to receive medical marijuana from that dispensary.
(d)(1) Each dispensary, cultivation center, and testing laboratory shall be registered with the Mayor prior to manufacturing, cultivating, dispensing, possessing, testing, or distributing medical marijuana, or manufacturing, possessing, using, or distributing paraphernalia.
(2)(A) No more than 5 dispensaries shall be registered to operate in the District; provided, that the Mayor may increase the number to as many as 8 by rulemaking to ensure that qualifying patients have adequate access to medical marijuana; provided further, that no more than 2 dispensaries shall be registered to operate within an election ward established by the Council in § 1-1041.03.
(B) The prohibition of no more than 2 dispensaries being registered to operate within an election ward set forth in subparagraph (A) of this paragraph shall apply to applications pending as of December 13, 2013.
(C)(i) No more than one dispensary may be registered to operate in any election ward in which 5 or more cultivation centers have been registered to operate.
(ii) The prohibition of no more than one dispensary being registered to operate within an election ward in which 5 or more cultivation centers have been registered to operate set forth in sub-subparagraph (i) of this subparagraph shall apply to applications pending as of December 13, 2013.
(3)(A) The number of cultivation centers and testing laboratories that may be registered to operate in the District shall be determined by rulemaking; provided, that the combined total number of cultivation centers and testing laboratories registered to operate within an election ward established by the Council in § 1-1041.03, shall not exceed 6.
(B) The prohibition of no more than 6 cultivation centers being registered to operate within an election ward set forth in subparagraph (A) of this paragraph shall apply to applications pending as of Dec. 13, 2013.
(4) The Mayor may approve the holder of a cultivation center registration that also owns, or has a valid lease for, real property adjacent to its existing cultivation center to physically expand the registered cultivation center into that adjacent real property for the purpose of increasing production of medical marijuana.
(5)(A) Any application for registration of a dispensary, cultivation center, or testing laboratory submitted by a certified business enterprise pursuant to this subsection after June 28, 2017, shall be awarded a preference equal to 20 points or 7.5% of the available points, whichever is more.
(B) For the purposes of this paragraph, the term "certified business enterprise" shall have the same meaning as provided in § 2-218.02(1D).
(e)(1) A dispensary may not dispense more than 2 ounces of medical marijuana in a 30-day period to a qualifying patient, either directly or through the qualifying patient’s caregiver; provided, that the Mayor, through rulemaking, may increase the quantity of medical marijuana that may be dispensed to up to 4 ounces.
(2) A cultivation center shall not possess more than 1,000 living marijuana plants at any time.
(3) It shall be unlawful for a dispensary to dispense or possess more than the quantity of medical marijuana needed to support the number of qualifying patients or caregivers registered to receive medical marijuana at that dispensary, as determined by the Mayor pursuant to rules issued under § 7-1671.13; provided, that the Mayor may allow a dispensary to possess a higher quantity of medical marijuana in anticipation of additional qualifying patients or caregivers registering.
(f) No marijuana or paraphernalia at a dispensary, cultivation center, or testing laboratory shall be visible from any public or other property.
(g) A dispensary, cultivation center, or testing laboratory shall not locate within any residential district or within 300 feet of a preschool, primary or secondary school, or recreation center.
(g-1)(1) A cultivation center shall not be located within a Retail Priority Area, as designated pursuant to § 2-1217.73, and as approved by the Council pursuant to the Great Streets Neighborhood Retail Priority Areas Approval Resolution of 2007, effective July 10, 2007 (Res. 17-257; 54 DCR 7194).
(2) Any applicant that had an application pending as of June 20, 2012, for a registration to operate a cultivation center within a Retail Priority Area as identified in paragraph (1) of this subsection, shall be allowed to modify the application within 180 days of May 1, 2013, without negatively affecting the current status of the application.
(g-2) A dispensary, cultivation center, or testing laboratory may be permitted to relocate within an election ward upon approval from the Mayor.
(g-3) A dispensary, cultivation center, or testing laboratory may be permitted to change ownership or controlling interest upon approval from the Mayor.
(3) Ensure that all of its employees receive training on compliance with District law, medical marijuana use, security, and theft prevention.
(i) Each dispensary shall regularly distribute to all qualifying patients and caregivers the educational materials regarding potential harmful drug interactions developed as part of the Program.
(j) No director, officer, member, incorporator, agent, or employee of a dispensary, cultivation center, or testing laboratory who has access to the medical marijuana at the dispensary, cultivation center, or testing laboratory shall have a felony conviction; provided, that the Mayor shall not disqualify any of the forgoing individuals solely for a felony conviction of possession with intent to distribute marijuana that occurred before the July 17, 2014.
(k) A person found to have violated any provision in this chapter shall not be a director, officer, member, incorporator, agent, or employee of a dispensary, cultivation center, or testing labor, and the registration identification card of the person shall be immediately revoked and the registration of the dispensary, cultivation center, or testing labor shall be suspended until the person is no longer a director, officer, member, incorporator, agent, or employee of the dispensary, cultivation center, or testing labor.
The 2013 amendment by D.C. Law 20-59 rewrote (d); and added (g-1).
The 2015 amendment by D.C. Law 20-189 substituted “500 living marijuana plants” for “95 living marijuana plants” in (e)(2).
For temporary (90 days) amendment of this section, see § 2 of Medical Marijuana Relocation Emergency Amendment Act of 2018 (D.C. Act 22-645, Feb. 6, 2019, 66 DCR 2052).
For temporary (90 days) amendment of this section, see § 2 of Medical Marijuana Certified Business Enterprise Preference Emergency Amendment Act of 2018 (D.C. Act 22-334, May 3, 2018, 65 DCR 5058).
For temporary (90 days) , see § 2 of Medical Marijuana Cultivation Center Relocation Congressional Review Emergency Amendment Act of 2017 (D.C. Act 22-109, July 28, 2017, 64 DCR 7394).
For temporary (90 days) amendment of this section, see § 2 of Medical Marijuana Certified Business Enterprise Preference Emergency Amendment Act of 2017 (D.C. Act 22-83, June 28, 2017, 64 DCR 6229).
For temporary (90 days) amendment of this section, see § 2 of Medical Marijuana Cultivation Center Relocation Emergency Amendment Act of 2017 (D.C. Act 22-74, June 5, 2017, 64 DCR 6078).
For temporary (90 days) amendment of this section, see § 2 of Medical Marijuana Dispensary Congressional Review Emergency Amendment Act of 2017 (D.C. Act 22-18, Mar. 17, 2017, 64 DCR 3055).
For temporary (90 days) amendment of this section, see § 2 of Medical Marijuana Dispensary Emergency Amendment Act of 2016 (D.C. Act 21-573, Dec. 19, 2016, 63 DCR 15689).
For temporary (90 days) amendment of this section, see § 2(b) of Medical Marijuana Cultivation Center Expansion Congressional Review Emergency Amendment Act of 2016 (D.C. Act 21-475, July 21, 2016, 63 DCR 10179).
For temporary (90 days) amendment of this section, see § 2 of Medical Marijuana Cultivation Center Relocation Emergency Amendment Act of 2016 (D.C. Act 21-427, June 23, 2016, 63 DCR 9022).
For temporary (90 days) amendment of this section, see § 2(b) of Medical Marijuana Cultivation Center Expansion Emergency Amendment Act of 2016 (D.C. Act 21-396, May 19, 2016, 63 DCR 7908).
For temporary (90 days) amendment of this section, see § 2(b) of Medical Marijuana Expansion Congressional Review Emergency Amendment Act of 2015 (D.C. Act 21-3, Feb. 19, 2015, 62 DCR 2468).
For temporary (90 day) amendment of section, see § 2 of Medical Marijuana Cultivation Center and Dispensary Locations Emergency Amendment Act of 2012 (D.C. Act 19-299, January 31, 2012, 59 DCR 902).
For temporary (90 day) amendment of section, see § 2 of Medical Marijuana Cultivation Center Emergency Amendment Act of 2012 (D.C. Act 19-339, April 7, 2012, 59 DCR 2784).
For temporary (90 days) amendment of this section, see § 2 of the Medical Marijuana Cultivation Center Emergency Amendment Act of 2013 (D.C. Act 20-4, January 29, 2013, 60 DCR 2790, 20 DCSTAT 438).
For temporary (90 days) amendment of this section, see § 2 of the Medical Marijuana Cultivation Center and Dispensary Location Restriction Emergency Act of 2013 (D.C. Act 20-18, March 1, 2013, 60 DCR 3972, 20 DCSTAT 474).
For temporary (90 days) amendment of this section, see § 2 of the Medical Marijuana Cultivation Center Congressional Review Emergency Act of 2013 (D.C. Act 20-61, April 27, 2013, 60 DCR 6401, 20 DCSTAT 1408).
For temporary (90 days) amendment of this section, see §§ 2 and 3 of the Medical Marijuana Cultivation Center Second Congressional Review Emergency Amendment Act of 2013 (D.C. Act 20-263, January 9, 2014, 61 DCR 328).
For temporary (90 days) amendment of this section, see § 2(b) of the Medical Marijuana Expansion Emergency Amendment Act of 2014 (D.C. Act 20-396, July 29, 2014, 61 DCR 8255).
For temporary (90 days) amendment of this section, see § 2(b) of the Medical Marijuana Expansion Congressional Review Emergency Amendment Act of 2014 (D.C. Act 20-479, Nov. 12, 2014, 61 DCR 12129, 20 STAT 4403).
For temporary (90 days) amendment of this section, see § 2 of the Medical Marijuana Cultivation Center Emergency Amendment Act of 2015 (D.C. Act 21-36, Mar. 30, 2015, 62 DCR 4548, 21 DCSTAT 876).
For temporary (90 days) amendment of this section, see § 2 of the Medical Marijuana Supply Shortage Emergency Amendment Act of 2015 (D.C. Act 21-53, May 6, 2015, 62 DCR 5950, 21 DCSTAT 1428).
For temporary (90 days) amendment of this section, see § 2 of the Medical Marijuana Cultivation Center Exception Emergency Amendment Act of 2015 (D.C. Act 21-64, May 22, 2015, 62 DCR 6863, 21 DCSTAT 1443).
For temporary (90 days) amendment of this section, see § 2(b) of the Medical Marijuana Cultivation Center Expansion Emergency Amendment Act of 2015 (D.C. Act 21-104, July 20, 2015, 62 DCR 9965).
For temporary (90 days) amendment of this section, see § 2(b) of the Medical Marijuana Cultivation Center Expansion Congressional Review Emergency Amendment Act of 2015 (D.C. Act 21-156, Oct. 16, 2015, 62 DCR 13707).
For temporary (225 days) amendment of this section, see § 2 of Medical Marijuana Certified Business Enterprise Preference Temporary Amendment Act of 2017 (D.C. Law 22-18, Sept. 6, 2017, 64 DCR 6715).
For temporary (225 days) amendment of this section, see § 2 of Medical Marijuana Cultivation Center Relocation Temporary Amendment Act of 2017 (D.C. Law 22-14, Aug. 19, 2017, 64 DCR 6247).
For temporary (225 days) amendment of this section, see § 2 of Medical Marijuana Dispensary Temporary Amendment Act of 2016 (D.C. Law 21-234, Apr. 1, 2017, 64 DCR 883).
For temporary (225 days) amendment of this section, see § 2 of Medical Marijuana Cultivation Center Relocation Temporary Amendment Act of 2016 (D.C. Law 21-162, Oct. 13, 2016, 63 DCR 9815).
For temporary (225 days) amendment of this section, see § 2(b) of Medical Marijuana Cultivation Center Expansion Temporary Amendment Act of 2016 (D.C. Law 21-146, Aug. 19, 2016, 63 DCR 9282).
For temporary (225 days) amendment of this section, see § 2 of the Medical Marijuana Cultivation Center and Dispensary Locations Temporary Amendment Act of 2012 (D.C. Law 19-122, Apr. 27, 2012, 59 DCR 1705).
For temporary (225 days) amendment of this section, see § 2 of the Medical Marijuana Cultivation Center Temporary Amendment Act of 2012 (D.C. Law 19-146, Jun. 20, 2012, 59 DCR 4164).
For temporary (225 days) amendment of this section, see § 2 of the Medical Marijuana Cultivation Center Temporary Amendment Act of 2013 (D.C. Law 20-1, May 1, 2013, 60 DCR 3962, 20 DCSTAT 1262).
For temporary (225 days) amendment of this section, see § 2 of the Medical Marijuana Cultivation Center and Dispensary Location Restriction Temporary Amendment Act of 2013 (D.C. Law 20-2, May 18, 2013, 60 DCR 4620, 20 DCSTAT 1264).
For temporary (225 days) amendment of this section, see § 2(b) of the Medical Marijuana Expansion Temporary Amendment Act of 2014 (D.C. Law 20-163, February 26, 2015, 60 DCR 10753).
For temporary (225 days) amendment of this section, see § 2 of the Medical Marijuana Supply Shortage Temporary Amendment Act of 2015 (D.C. Law 21-18, July 22, 2015, 62 DCR 6880).
For temporary (225 days) amendment of this section, see § 2 of the Medical Marijuana Cultivation Center Exception Temporary Amendment Act of 2015 (D.C. Law 21-22, Sept. 17, 2015, 62 DCR 8850).
For temporary (225 days) amendment of this section, see § 2(b) of the Medical Marijuana Cultivation Center Expansion Temporary Amendment Act of 2015 (D.C. Law 21-33, Oct. 21, 2015, 62 DCR 10896).
(a) The Boards of Medicine, Nursing, and Dentistry" shall have the authority to review and audit the written authorized practitioner recommendations submitted to the Department as part of the registration process and shall have the authority to discipline authorized practitioners under their licensing authority who act outside of the scope of this chapter.
(b) The relevant licensing board shall audit the recommendations submitted by any authorized practitioner who provides more than 250 recommendations in any 12-month period to patients for the use of medical marijuana.
(c) Submitting a false statement regarding a qualifying patient’s eligibility to participate in the Program on the form developed pursuant to § 7-1761.04(b)(2) shall be grounds for the revocation, suspension, or denial of an authorized practitioner's license, or the imposition of a civil fine pursuant to § 3-1205.14(c), or both, at the licensing board's discretion.
This section is referenced in § 3-1202.03 and § 7-1671.04.
(a) Any person who manufactures, cultivates, possesses, administers, dispenses, distributes, or uses marijuana, or manufactures, possesses, distributes, or uses paraphernalia, in a manner not authorized by this chapter or the rules issued pursuant to § 7-1671.13 shall be subject to criminal prosecution and sanction under subchapter I of Chapter 11 of Title 48 [§ 48-1101 et seq.].
(b) Any person who makes a fraudulent representation to a law enforcement official of any fact or circumstance relating to the person’s manufacture, cultivation, possession, administration, dispensing, distribution, or use of medical marijuana, or manufacture, possession, distribution, or use of paraphernalia, to avoid arrest or prosecution shall be subject to a criminal fine not to exceed $1,000. The imposition of the fine shall be in addition to any other penalties that may otherwise apply for the making of a false statement or for the manufacture, cultivation, possession, administration, dispensing, distribution, or use of marijuana, or the manufacture, possession, distribution, or use of paraphernalia.
(4) Is 18 years of age or older.
(d) Civil fines, penalties, and fees may be imposed as sanctions for any infraction of the provisions of this chapter, or any rules issued under § 7-1671.13, pursuant to Chapter 18 of Title 2 [§ 2-1801.01 et seq.]. Adjudication of any infraction of this chapter shall be pursuant to Chapter 18 of Title 2 [§ 2-1801.01 et seq.].
(3) The effectiveness of the District’s medical marijuana program.
(3) Any other comments the Committee believes to be important.
(a) The Mayor is authorized to establish, by rulemaking, fees for the registration of caregivers, cultivation centers, dispensaries, testing laboratories, and qualifying patients and for the inspection and audit of cultivation centers, dispensaries, and testing laboratories.
(b) Any of the fees collected pursuant to this chapter shall be applied first toward the cost of administering this chapter.
(a) No liability shall be imposed by virtue of this chapter upon any duly authorized District officer engaged in the enforcement of any law relating to controlled substances.
(b) The District shall not be held liable for any deleterious outcomes from the use of medical marijuana, including the acts or omissions of any qualifying patient attributed to the use of medical marijuana.
Nothing in this chapter shall require a governmental, private, or any other health insurance provider or health care service plan to be liable for any claim for reimbursement for the use of medical marijuana.
(B) Change ownership or controlling interest pursuant to § 7-1671.06(g-3).
(b) The Mayor shall submit the proposed rules to the Council for a 30-day period of review, excluding Saturdays, Sundays, legal holidays, and days of Council recess. If the Council does not approve or disapprove the proposed rules, in whole or in part, by resolution, within this 30-day review period, the proposed rules shall be deemed approved.
This section is referenced in § 7-1671.01, § 7-1671.02, § 7-1671.03, § 7-1671.04, § 7-1671.05, § 7-1671.06, and § 7-1671.08.

References: § 7

§ 7

§ 7

§ 7

§ 7
 § 48
 § 7
 § 7
 § 7
 § 48
 § 7
 § 7
 § 7
 § 3
 § 48
 § 48
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 v. 
 § 7
 § 7
 § 7
 § 4
 § 2
 § 7
 § 7
 § 7
 § 7
 § 3
 § 7
 § 7
 § 7
 § 7
 § 1
 § 1
 § 2
 § 7
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 2
 § 7
 § 3
 § 3
 § 7
 § 7
 § 7
 § 7
 § 7
 § 7
 § 7
 § 7
 § 7
 § 7
 § 7